BCTXL BriaCell Therapeutics Corp. Warrant expiring 2031

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

BCTXL — —
Key stats
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Employees
31
List Date
2026-01-14
CIK
0001610820
Headquarters
West Vancouver, A1
Homepage
https://www.briacell.com

BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab in a pivotal Phase 3 study in metastatic breast cancer. The Company's operations focus on the research and development of its immunotherapy product candidates and related supporting activities.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'26Avg
Jan23.66%23.66%
Feb-17.50%-17.50%
Mar4.83%4.83%
Apr-8.26%-8.26%
May-9.09%-9.09%
Jun6.57%6.57%
Jul3.37%3.37%
Aug0.55%0.55%
Sep23.40%23.40%
Oct-34.11%-34.11%
Nov30.67%*30.67%
Dec----
Total4.97%4.97%
* Only 1 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $0.88
SMA 50: $0.97
SMA 200: —
Current: $0.98
EMA 12: $0.90
EMA 26: $0.92
MACD: -0.0182 | Signal: 0.0184
BEARISH
ADX (14): 31.11
TREND
+DI: 18.35
−DI: 29.47

Momentum Oscillators

RSI (14): 54.67
NEUTRAL
Stoch %K: 85.43
Stoch %D: 73.95
Williams %R: -20.00

Volume & Volatility

BB Upper: $1.00
BB Lower: $0.76
NEUTRAL
OBV: -372,330
Vol SMA 20: 20,039
Vol ROC: 503.03%
ATR: $0.10
True Range: $0.17
HV 20: 115.5%
HV 30: 104.4%
HV 60: 109.6%

Data Summary

Data Points: 198
Last Updated:
Date Range: 2026-01-14T00:00:00 – 2026-11-10T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall Assessment: NEUTRAL (Confidence Level: 6/10)

Key Drivers:

  • Technical trend is weak, but momentum indicators suggest a potential uptrend
  • News sentiment is positive, with recent earnings announcement

Primary Risks:

  • High volatility may lead to sudden price movements
  • Lack of institutional interest and trading activity could impact market participation

Investment Thesis: BCTXL's technical signals are mixed, but the recent earnings announcement and moderate volatility suggest a potentially stable trading range.

Recent News Sentiment Impact: The positive news headline about the pricing of an offering has contributed to the neutral sentiment assessment.

Technical Analysis

Trend Direction:

  • Short-term (1-4 weeks): Uptrend
  • Medium-term (1-3 months): Neutral
  • Long-term (3-12 months): Downtrend

Support/Resistance Levels:

  • Resistance: $1.05 (Upper Bollinger Band)
  • Support: $0.80 (Lower Bollinger Band)

Momentum Signals:

  • RSI interpretation: Neutral (51.38), no clear buy or sell signal
  • MACD signal: Bullish (0.02 / -0.00 / 0.02), indicating a potential uptrend
  • Bollinger Bands position: Neutral, with the price near the middle band

Volume Analysis:

  • Volume SMA 20: 11041.15, indicating moderate trading activity
  • On-Balance Volume (OBV): -240049.28, suggesting bearish momentum
  • Volume Rate of Change: -86.56%, indicating a decrease in trading volume

News & Sentiment Analysis

Recent Headlines Summary:

  • Positive news headline about the pricing of an offering on 2026-05-31

Sentiment Assessment:

  • Aggregate news sentiment: Positive (1/3)

Catalyst Identification:

  • Earnings date: Not available
  • Product launches: None recent
  • Regulatory changes: None recent

Market Narrative:

  • News aligns with technical signals, suggesting a potentially stable trading range.

Risk & Volatility Assessment

Beta Interpretation:

  • Beta: 0.91 (vs SPY), indicating moderate volatility

Volatility Regime:

  • Current vs historical volatility levels: Higher than average

Options Market Signals:

  • IV rank: Not available
  • Put/call ratios: Not available
  • Unusual activity: None recent

Downside Protection:

  • Support levels: $0.80 (Lower Bollinger Band)
  • Risk management considerations: Moderate stop-loss levels and position sizing.

Market Context & Positioning

Sector Performance:

  • Relative strength vs sector/market: Neutral

Institutional Activity:

  • Volume patterns suggesting institutional interest: None recent

Correlation Analysis:

  • How stock moves relative to market (R-squared interpretation): 0.11, indicating a moderate correlation

Relative Valuation:

  • Position within trading range: Stable, with a potential uptrend.

Key Levels & Action Items

Critical Price Levels:

  • Support/resistance to monitor: $1.05 (Upper Bollinger Band) and $0.80 (Lower Bollinger Band)

Breakout/Breakdown Levels:

  • Technical levels that could trigger significant moves: $1.05 and $0.80

Time-Sensitive Catalysts:

  • Earnings date: Not available
  • Product launches: None recent
  • Regulatory changes: None recent

Risk Management:

  • Stop-loss levels and position sizing considerations: Moderate risk, with a potential uptrend.

Note: This report is for information purposes only and should not be considered as investment advice.

Generated
News
All BCTXL news →

BCTXL Options Activity & IV Rank

Loading options activity...
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 0.9384
Alpha: 52.52%
Correlation: 0.1232
R-Squared: 1.5%
Stock Volatility: 110.0%
Market Volatility: 14.4%

Analysis Details

Benchmark: SPY
Data Points: 197
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Notable investors who own BCTXL
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$717K
0.00%
#4078 of 6285-14.6%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

BCTXL Institutional Ownership (13F)

Filings for 2026-06-30 · 2 already for 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

10 filers2,977,956 shares$2.62M value
# Filer Shares Value % of Total % of Float Period
1 Citadel Advisors LLC Custodian 895,864 $716.78K 27.36% — 2026-06-30
2 ARMISTICE CAPITAL, LLC 536,600 $477.57K 18.23% — 2026-06-30
3 Cable Car Capital, LP 321,898 $286.49K 10.94% — 2026-06-30
4 Empery Asset Management, LP 300,000 $267.00K 10.19% — 2026-06-30
5 Warberg Asset Management LLC 181,612 $210.67K 8.04% — 2026-09-30
6 MYDA Advisors LLC 195,821 $174.28K 6.65% — 2026-06-30
7 SABBY MANAGEMENT, LLC 190,383 $169.44K 6.47% — 2026-06-30
8 HEIGHTS CAPITAL MANAGEMENT, INC 186,582 $149.28K 5.70% — 2026-06-30
9 Clear Street Group Inc. 104,196 $92.73K 3.54% — 2026-06-30
10 IRIDIAN ASSET MANAGEMENT LLC/CT 65,000 $75.40K 2.88% — 2026-09-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Recent SEC Filings
Latest: 2026-10-28
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-06-26 Regulation FD disclosure EDGAR
2026-06-03 Material agreement · Unregistered share sale · Other events EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-10-28 0001493152-26-049041 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-06-09 0001493152-26-027928 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

BCTXL vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
LLY Eli Lilly & Co. $1.26T 46.0 +45.5% +31.2% 29
JNJ Johnson & Johnson $679.1B 42.1 +7.8% +34.0% 67
ABBV ABBVIE INC. $518.4B 50.2 +10.7% +27.1% 32
MRK Merck & Co., Inc. $366.7B 150.8 +4.9% +37.4% 37
NVS Novartis AG $309.1B — — +15.5% 39
AZN AstraZeneca PLC $293.7B — — +101.5% 0
ABT Abbott Laboratories $191.4B 40.6 +10.0% −11.6% 18
NVO Novo-Nordisk A/S $182.4B — — −22.9% 16
BCTXL BriaCell Therapeutics Corp. Warrant expi — — — +5.4% —
Peer median $337.9B 46.0 +10.0% +29.1% 30

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.